Cargando…

Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach

Detalles Bibliográficos
Autor principal: Motoo, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874331/
https://www.ncbi.nlm.nih.gov/pubmed/29151542
http://dx.doi.org/10.2169/internalmedicine.9709-17
_version_ 1783310144389513216
author Motoo, Yoshiharu
author_facet Motoo, Yoshiharu
author_sort Motoo, Yoshiharu
collection PubMed
description
format Online
Article
Text
id pubmed-5874331
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-58743312018-03-29 Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach Motoo, Yoshiharu Intern Med Editorial The Japanese Society of Internal Medicine 2017-11-20 2018-03-01 /pmc/articles/PMC5874331/ /pubmed/29151542 http://dx.doi.org/10.2169/internalmedicine.9709-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Motoo, Yoshiharu
Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach
title Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach
title_full Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach
title_fullStr Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach
title_full_unstemmed Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach
title_short Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach
title_sort ramucirumab plus paclitaxel: a possible new chemotherapy regimen for neuroendocrine carcinoma of the stomach
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874331/
https://www.ncbi.nlm.nih.gov/pubmed/29151542
http://dx.doi.org/10.2169/internalmedicine.9709-17
work_keys_str_mv AT motooyoshiharu ramucirumabpluspaclitaxelapossiblenewchemotherapyregimenforneuroendocrinecarcinomaofthestomach